Pseudodrynaria Coronana (Wall) Ching

National Taiwan University logo

National Taiwan University

Status and phase

Completed
Phase 1

Conditions

Osteoporosis

Treatments

Drug: GUSUIBU

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00155675
900505
CCMP90-RD-114

Details and patient eligibility

About

The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.

Full description

Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postmenpausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal woman with established osteoporosis.

Enrollment

120 estimated patients

Sex

Female

Ages

45 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

postmenopausal osteoporosis

Exclusion criteria

Insulin dependent diabetes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems